Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 Biomarker phenotype BEFREE CEA may play a functional role in tumour progression. 27165139 2017
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.100 Biomarker phenotype BEFREE β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-<i>N</i>-Glycan Complex. 29549127 2018
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.100 Biomarker phenotype BEFREE β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-<i>N</i>-Glycan Complex. 29549127 2018
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.100 Biomarker phenotype BEFREE β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-<i>N</i>-Glycan Complex. 29549127 2018
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.100 Biomarker phenotype BEFREE β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-<i>N</i>-Glycan Complex. 29549127 2018
Entrez Id: 1728
Gene Symbol: NQO1
NQO1
0.050 Biomarker phenotype BEFREE β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. 28578385 2017
Entrez Id: 3958
Gene Symbol: LGALS3
LGALS3
0.100 Biomarker phenotype BEFREE β-d (1→4) linked galactose being the specific sugar for galectin-3, SRO1 had potentials in inhibiting galectin-3 mediated cancer progression. 29456003 2018
Entrez Id: 8703
Gene Symbol: B4GALT3
B4GALT3
0.010 AlteredExpression phenotype BEFREE β-1,4-Galactosyltransferase III (B4GALT3) is highly expressed in human fetal brain and is responsible for the generation of poly-N-acetyllactosamine, which plays a critical role in tumor progression. 23444218 2013
Entrez Id: 1496
Gene Symbol: CTNNA2
CTNNA2
0.010 AlteredExpression phenotype BEFREE α-Catulin, an α-catenin-related protein, is reported to have tumorigenic potential because it regulates the nuclear factor-κB (NF-κB) pathway, but little is known about its clinical relevance and the mechanism through which it regulates cancer progression. 21278790 2011
Entrez Id: 23136
Gene Symbol: EPB41L3
EPB41L3
0.020 Biomarker phenotype BEFREE [Corrigendum] Pivotal roles of protein 4.1B/DAL‑1, a FERM‑domain containing protein, in tumor progression (Review). 31814035 2020
Entrez Id: 406971
Gene Symbol: MIR195
MIR195
0.080 Biomarker phenotype BEFREE ZNF367 inhibits cancer progression and is targeted by miR-195. 25047265 2014
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker phenotype BEFREE Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination. 31521611 2019
Entrez Id: 1107
Gene Symbol: CHD3
CHD3
0.010 Biomarker phenotype BEFREE Zinc-finger E-box binding homeobox 1 (ZEB-1), a member of the ZFH family, plays a key role in epithelial-mesenchymal transition during tumor progression in various cancers. 28243114 2017
Entrez Id: 2863
Gene Symbol: GPR39
GPR39
0.010 Biomarker phenotype BEFREE Zinc, its ligand, is accumulated at larger concentrations in the tumor tissue and can therefore activate ZnR/GPR39-dependent Ca<sup>2+</sup> signaling leading to tumor progression. 31146164 2019
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.100 Biomarker phenotype BEFREE Zinc finger E-box binding protein 1 (ZEB1) and ZEB2 induce epithelial-mesenchymal transition (EMT) and enhance cancer progression. 28618162 2017
Entrez Id: 29979
Gene Symbol: UBQLN1
UBQLN1
0.010 Biomarker phenotype BEFREE ZEB1 promotes the EMT process by controlling the expression of E-cadherin and may have a reciprocal regulation with Ubiquilin1 (UBQLN1) and mir-200 family in cancer progression. 28212565 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation phenotype BEFREE Yet, replication-mediated genomic instability is integral to oncogenesis, and p53 mutations promote tumor progression and drug-resistance. 29334356 2018
Entrez Id: 25937
Gene Symbol: WWTR1
WWTR1
0.060 Biomarker phenotype BEFREE Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both emerged as important drivers of cancer progression and metastasis. 29642615 2018
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker phenotype BEFREE YEATS Domain Containing 4 Promotes Gastric Cancer Cell Proliferation and Mediates Tumor Progression via Activating the Wnt/β-Catenin Signaling Pathway. 28251887 2017
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.100 AlteredExpression phenotype BEFREE YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. 15042610 2004
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.030 Biomarker phenotype BEFREE X‑linked inhibitor of apoptosis (XIAP), a key member of the inhibitors of apoptosis protein family, can inhibit apoptosis by directly binding to the initiator caspase‑9, ‑3 and ‑7, thereby promoting tumor cell survival during tumor progression. 29115633 2018
Entrez Id: 286827
Gene Symbol: TRIM59
TRIM59
0.020 Biomarker phenotype BEFREE Xenograft tumor model was established with TRIM59-deficient H1975 cells, and tumor progression was monitored. 30932261 2019
Entrez Id: 10761
Gene Symbol: PLAC1
PLAC1
0.040 Biomarker phenotype BEFREE Xenograft mouse assays revealed that PLAC1 TCR-transduced CD8+T cells significantly delayed the tumor progression in mice-bearing breast cancer compared with normal saline or negative control-transduced groups. 29556312 2018
Entrez Id: 2463
Gene Symbol: FRA16D
FRA16D
0.010 Biomarker phenotype BEFREE WWOX is a tumor suppressor gene that maps to the common fragile site FRA16D and is involved in carcinogenesis and cancer progression in many different carcinomas. 23197378 2013
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.100 Biomarker phenotype BEFREE WW domain containing E3 Ub-protein ligase 2 (WWP2) plays an important role in tumor progression as an E3 ligase of PTEN. 31677789 2020